Malignant Testicular Neoplasm
specificA primary or metastatic malignant neoplasm that affects the testis. Representative examples include malignant germ cell tumors, sarcomas, leukemias, and lymphomas.
14
Centers
15
Active Trials
—
Cancer Funding
Top Centers for Malignant Testicular Neoplasm(14)
Ranked by research excellence score (trials · grants · publications). Methodology →
| # | Center | Score |
|---|---|---|
| 1 | UCLA Jonsson Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive High-Volume Research Center | 74.5 |
| 2 | Memorial Sloan Kettering Cancer CenterNew York, NY NCI Comprehensive Active Research Program | 52.0 |
| 3 | Dana-Farber Cancer InstituteBoston, MA NCI Comprehensive Active Research Program | 52.0 |
| 4 | Winship Cancer InstituteAtlanta, GA NCI Comprehensive Active Research Program | 52.0 |
| 5 | The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive Active Research Program | 52.0 |
| 6 | NCI Comprehensive Active Research Program | 52.0 |
| 7 | City of Hope Comprehensive Cancer CenterDuarte, CA NCI Comprehensive Active Research Program | 52.0 |
| 8 | USC Norris Comprehensive Cancer CenterLos Angeles, CA NCI Comprehensive Active Research Program | 52.0 |
| 9 | Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program | 52.0 |
| 10 | Case Comprehensive Cancer CenterCleveland, OH NCI Comprehensive Active Research Program | 52.0 |
| 11 | Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive Active Research Program | 52.0 |
| 12 | Boston University Cancer CenterBoston, MA Active Research Program | 52.0 |
| 13 | Karmanos Cancer InstituteDetroit, MI NCI Comprehensive Active Research Program | 52.0 |
| 14 | Penn State Cancer InstituteHershey, PA Active Research Program | 52.0 |
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →